11.2 Labeling & Packaging of Dispensed Drugs

11.2 Labeling & Packaging of Dispensed Drugs

Quick Answer: Under 225 ILCS 85 §22, the label on an outpatient dispensed prescription container must show the pharmacy name and address, name or initials of the person authorized to practice pharmacy who sold/dispensed it, fill date, patient name, prescription serial number, prescriber’s last name, directions for use, and the proprietary or established name(s), dosage, and quantity. Pair that with PPPA child-resistant packaging, appropriate auxiliary labels, and a lawful beyond-use date. Institutional unit-dose labeling is a different model—do not paste retail vial rules onto every hospital dose.

After a transfer or original adjudication succeeds, the physical product must leave the pharmacy in a lawful package with a complete label. Labeling failures are high-visibility IDFPR and civil-liability problems because the patient uses the label every day.

Illinois Outpatient Label Elements (225 ILCS 85 §22)

Section 22 states that when a drug is dispensed pursuant to a prescription of an authorized practitioner, the label on the box, bottle, vessel, or package shall show:

The statute also notes that drug name/dosage/quantity appear except as otherwise authorized by Department rule—so do not invent permanent exceptions on the exam unless the stem supplies a recognized rule pathway.

Federal floor (still tested)

Federal dispensed-prescription labeling under the FD&C Act / Durham-Humphrey framework expects patient-specific directions for use and identifying information for the dispensed product. The Illinois MPJE bank theme is consistent: patient SSN and technician DEA numbers are not federal label requirements. When federal and Illinois both apply, put all required Illinois elements on the label—satisfying only a thin federal minimum is not enough for Illinois practice.

What is not a substitute for label elements

• Insurance BIN/PCN/group numbers
• Copay stickers alone
• Manufacturer stock bottle labeling left visible without a pharmacy label
• Bag tags that fall off and never reach the container the patient stores at home

If the vial the patient takes home is incomplete, the pharmacy failed—even if the computer screen looked perfect.

Auxiliary Labels and Counseling-Linked Warnings

Auxiliary labels (take with food, may cause drowsiness, shake well, avoid alcohol, finish all medication, external use only) are not a complete list in §22, but they are standard professional practice and often intertwined with counseling duties and manufacturer warnings. High-yield habits:

• Match auxiliaries to drug risk (e.g., opioids and benzodiazepines → drowsiness/alcohol; antibiotics suspensions → shake well/refrigerate when required)
• Do not use auxiliaries as a substitute for verbal counseling when counseling is required
• Ensure auxiliaries do not obscure required primary label elements

Medication Guides, REMS materials, and PPI/leaflets may be required for specific products under FDA programs—those are additional to the vial label, not replacements for §22 elements.

Child-Resistant Packaging (PPPA)

The federal Poison Prevention Packaging Act (PPPA) generally requires child-resistant (CR) packaging for oral prescription drugs dispensed for household use. Exam classics:

Illinois community practice still operates under this federal packaging floor. A correctly labeled amoxicillin suspension in a non-CR vial without a valid exemption/request is still a packaging violation.

Beyond-Use Dates on Labels

A beyond-use date (BUD) tells the patient the last date the pharmacy stands behind the product as labeled under its storage conditions. Illinois administrative definitions even define “Beyond Use Date” in relation to drug dating for practice rules. Practical dispensing rules of thumb for MPJE teaching (without inventing product-specific chemistry):

• Do not assign a BUD beyond the manufacturer’s expiration for the stock used
• For reconstituted products, follow manufacturer stability (often days under refrigeration)—print the shorter date, not the stock bottle’s multi-year expiration
• For prepackaged drugs under 68 Ill. Adm. Code 1330.730, prepack labels need name and strength, manufacturer/distributor, BUD, and lot; maximum prepack BUD is the manufacturer’s date or 12 months, whichever is less
• Automated counting devices may keep lot/BUD in traceable, inspectable records instead of every cassette label only when the rule’s alternative-record pathway is met

Trap: Printing a one-year BUD on a reconstituted antibiotic that expires in 10 days after mixing.

Institutional / Unit-Dose Labeling (High Level)

Community outpatient vials and institutional unit-dose systems solve different problems.

When a hospital discharges a patient with a facility-provided take-home supply, labeling expectations shift back toward outpatient completeness. Do not assume every institutional strip label is enough for community take-home dispensing.

Multi-med packaging note

Illinois also regulates patient med paks (multi-med dispensing) under 1330.740: with consent, solid orals may be packaged by dosing time with expanded label content (patient name, serials, each drug’s identity/quantity, directions, storage, prescribers, preparation date, pharmacy identity, and BUD rules). If a vignette describes a med pak, look for consent and per-drug identification, not only a single drug name.

Practical Labeling Workflow

1. Select correct product (NDC, strength, form)
2. Assign serial number and capture dispenser identity
3. Generate label with all §22 elements
4. Choose CR packaging unless exemption/request applies
5. Add auxiliaries and required MedGuides/REMS handouts
6. Set BUD from manufacturer data + preparation conditions
7. Final verification against hard copy/eRx before release
8. Counsel when required (Chapter 9)—label text is not a full counseling substitute

Exam Scenarios

Scenario A. Label missing prescriber last name and Rx serial number → incomplete under §22 even if drug name and patient name appear.

Scenario B. Patient requests easy-open caps for arthritis → document request; non-CR allowed; still keep complete label.

Scenario C. Sublingual nitroglycerin dispensed in non-CR packaging → generally consistent with PPPA exemption purpose (emergency access).

Scenario D. Unit-dose hospital cart fill labeled with drug/strength/lot/BUD but no full outpatient directions on each blister → ordinary for inpatient unit-dose; different from community take-home vial standards.

Common Traps

• Omitting pharmacy address or Rx serial number
• Treating insurance fields as legal label content
• Ignoring PPPA defaults
• BUD longer than product stability after reconstitution or prepack limits
• Applying full community label rules to every institutional unit dose—or the reverse, sending patients home with incomplete institutional stickers

Master §22 elements, PPPA packaging, BUD discipline, and the community vs institutional split. Section 11.3 covers which product may go in that labeled vial when brand and generic both exist.